Literature DB >> 19453547

2009 update on the classification of renal epithelial tumors in adults.

Antonio Lopez-Beltran1, Jose C Carrasco, Liang Cheng, Marina Scarpelli, Ziya Kirkali, Rodolfo Montironi.   

Abstract

The classification of kidney tumors in adults expands rapidly with new categories recently incorporated. This will result in the modification of the current 2004 World Health Organization (WHO) classification of the adult renal epithelial neoplasms. Emphasis should be placed in defining risk groups categorized as malignant or benign tumors, including a category of tumors with low malignant potential to accommodate recently recognized categories with extremely good prognosis after surgery. Unusual tumors such as familial renal cell carcinoma (RCC), translocation RCC, renal cell carcinoma after neuroblastoma, tubular mucinous and spindle cell carcinoma, and mixed epithelial and stromal tumors are also presented. A number of recently described entities and morphologic variants of classical categories deserve recognition since they can be important in differential diagnosis. This review emphasizes clinical, pathological and genetic features defining renal epithelial tumors in adults.

Entities:  

Mesh:

Year:  2009        PMID: 19453547     DOI: 10.1111/j.1442-2042.2009.02302.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  78 in total

Review 1.  Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach.

Authors:  Shankar Siva; Gargi Kothari; Alexander Muacevic; Alexander V Louie; Ben J Slotman; Bin S Teh; Simon S Lo
Journal:  Nat Rev Urol       Date:  2017-06-20       Impact factor: 14.432

2.  Mutational status of VHL gene and its clinical importance in renal clear cell carcinoma.

Authors:  Mariana Rezende Alves; Felipe Cavalcanti Carneiro; André Mourão Lavorato-Rocha; Walter Henriques da Costa; Isabela Werneck da Cunha; Stênio de Cássio Zequi; Gustavo Cardoso Guimaraes; Fernando Augusto Soares; Dirce Maria Carraro; Rafael Malagoli Rocha
Journal:  Virchows Arch       Date:  2014-07-16       Impact factor: 4.064

Review 3.  [Molecular tumor board-renal cell carcinoma].

Authors:  V Grünwald; C Doehn; P J Goebell
Journal:  Urologe A       Date:  2019-07       Impact factor: 0.639

Review 4.  [Risk-adapted (immuno)therapy for renal cell carcinoma].

Authors:  V Grünwald
Journal:  Urologe A       Date:  2018-11       Impact factor: 0.639

Review 5.  Imaging of Solid Renal Masses.

Authors:  Fernando U Kay; Ivan Pedrosa
Journal:  Urol Clin North Am       Date:  2018-06-15       Impact factor: 2.241

6.  Diagnostic Performance and Interreader Agreement of a Standardized MR Imaging Approach in the Prediction of Small Renal Mass Histology.

Authors:  Fernando U Kay; Noah E Canvasser; Yin Xi; Daniella F Pinho; Daniel N Costa; Alberto Diaz de Leon; Gaurav Khatri; John R Leyendecker; Takeshi Yokoo; Aaron H Lay; Nicholas Kavoussi; Ersin Koseoglu; Jeffrey A Cadeddu; Ivan Pedrosa
Journal:  Radiology       Date:  2018-02-01       Impact factor: 11.105

Review 7.  Renal Cell Carcinoma: Molecular Aspects.

Authors:  Aman Kumar; Niti Kumari; Vinny Gupta; Rajendra Prasad
Journal:  Indian J Clin Biochem       Date:  2017-11-13

Review 8.  Precision medicine from the renal cancer genome.

Authors:  Yasser Riazalhosseini; Mark Lathrop
Journal:  Nat Rev Nephrol       Date:  2016-10-03       Impact factor: 28.314

9.  Development and validation of a microRNA-based diagnostic assay for classification of renal cell carcinomas.

Authors:  Yael Spector; Eddie Fridman; Shai Rosenwald; Sofia Zilber; Yajue Huang; Iris Barshack; Orit Zion; Heather Mitchell; Mats Sanden; Eti Meiri
Journal:  Mol Oncol       Date:  2013-03-26       Impact factor: 6.603

10.  Determination of angptl4 mRNA as a diagnostic marker of primary and metastatic clear cell renal-cell carcinoma.

Authors:  Jérôme Verine; Jacqueline Lehmann-Che; Hany Soliman; Jean-Paul Feugeas; Jean-Sébastien Vidal; Pierre Mongiat-Artus; Stéphanie Belhadj; Josette Philippe; Matthieu Lesage; Evelyne Wittmer; Stéphane Chanel; Anne Couvelard; Sophie Ferlicot; Nathalie Rioux-Leclercq; Jean-Michel Vignaud; Anne Janin; Stéphane Germain
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.